Characteristics of patients analyzed in this study
| Patient no. . | Age, y . | White blood cell count, ×103/μL . | HLA-A0201 . | Stage at diagnosis . | Cytogenetic remission . | Remission time points analyzed . |
|---|---|---|---|---|---|---|
| P1 | 67 | 73 | Negative | Chronic | Complete (at 6 mo) | 5, 30, 35, 46 mo |
| P2 | 57 | 20 | Positive | Chronic | Complete (at 6 mo) | 5, 11, 12, 15 mo |
| P3 | 27 | 18.9 | Negative | Accelerated | Complete (at 6 mo) | 6 mo |
| P4 | 69 | 23.1 | Negative | Chronic | Complete (at 6 mo) | 6, 9, 18, 24, 32, 34, 42 mo |
| P5 | 60 | 53.3 | Negative | Chronic | Complete (at 6 mo) | 6, 10, 24, 36 mo |
| P6 | 36 | 40 | Negative | Chronic | Complete (at 7 mo) | 13 mo |
| P7 | 35 | 43.4 | Positive | Chronic | Complete (at 9 mo) | 10 mo |
| P8 | 82 | 30.1 | Positive | Chronic | Complete (at 1 y) | 12, 15 mo |
| P9 | 53 | 26.5 | Negative | Accelerated | Major (20% Ph+ cells at 6 mo), complete (at 2 y), relapse at 3 y | 16 mo |
| P10 | 32 | 130 | Negative | Accelerated | Major (20% Ph+ cells at 6 mo), complete (at 1.5 y) | 3, 4, 6, 24, 27, 30 mo |
| P11 | 43 | 99.5 | Positive | Chronic | Major (20% Ph+ cells at 4 mo) | 4 (BM), 5 mo |
| P12 | 46 | 116.8 | Negative | Chronic | Major (20% Ph+ cells at 5 mo) | 2, 5, 9, 13, 15, 24, 30 mo |
| P13 | 64 | 40.8 | Negative | Chronic | Major (10% Ph+ cells at 6 mo), relapse at 4 y | 8, 12, 15, 19, 24, 26, 30 mo |
| P14 | 28 | 523 | Negative | Accelerated | Major (10% Ph+ cells at 4 mo) | 1, 3, 5 mo |
| Patient no. . | Age, y . | White blood cell count, ×103/μL . | HLA-A0201 . | Stage at diagnosis . | Cytogenetic remission . | Remission time points analyzed . |
|---|---|---|---|---|---|---|
| P1 | 67 | 73 | Negative | Chronic | Complete (at 6 mo) | 5, 30, 35, 46 mo |
| P2 | 57 | 20 | Positive | Chronic | Complete (at 6 mo) | 5, 11, 12, 15 mo |
| P3 | 27 | 18.9 | Negative | Accelerated | Complete (at 6 mo) | 6 mo |
| P4 | 69 | 23.1 | Negative | Chronic | Complete (at 6 mo) | 6, 9, 18, 24, 32, 34, 42 mo |
| P5 | 60 | 53.3 | Negative | Chronic | Complete (at 6 mo) | 6, 10, 24, 36 mo |
| P6 | 36 | 40 | Negative | Chronic | Complete (at 7 mo) | 13 mo |
| P7 | 35 | 43.4 | Positive | Chronic | Complete (at 9 mo) | 10 mo |
| P8 | 82 | 30.1 | Positive | Chronic | Complete (at 1 y) | 12, 15 mo |
| P9 | 53 | 26.5 | Negative | Accelerated | Major (20% Ph+ cells at 6 mo), complete (at 2 y), relapse at 3 y | 16 mo |
| P10 | 32 | 130 | Negative | Accelerated | Major (20% Ph+ cells at 6 mo), complete (at 1.5 y) | 3, 4, 6, 24, 27, 30 mo |
| P11 | 43 | 99.5 | Positive | Chronic | Major (20% Ph+ cells at 4 mo) | 4 (BM), 5 mo |
| P12 | 46 | 116.8 | Negative | Chronic | Major (20% Ph+ cells at 5 mo) | 2, 5, 9, 13, 15, 24, 30 mo |
| P13 | 64 | 40.8 | Negative | Chronic | Major (10% Ph+ cells at 6 mo), relapse at 4 y | 8, 12, 15, 19, 24, 26, 30 mo |
| P14 | 28 | 523 | Negative | Accelerated | Major (10% Ph+ cells at 4 mo) | 1, 3, 5 mo |